BDTX News
Archived Headlines
- US IPO Weekly Recap: One Medical pops 58 percent in 5-IPO week 01/31/20
- Oncology biotech Black Diamond Therapeutics pops 108% on IPO 01/30/20
- Black Diamond Therapeutics prices upsized IPO above the range at $19 01/30/20
- US IPO Week Ahead: Reynolds attempts first billion-dollar IPO of 2020 in 5-IPO week 01/24/20
- US IPO Weekly Recap: IPO calendar fills up with 5 launches 01/24/20
See more
US IPO Week Ahead: Chinese EVs and US tax software lead a diverse 7 IPO week
Seven IPOs and one SPAC plan to raise $2.1 billion in the week ahead, led by tax software provider Vertex (VERX). A handful of companies could join the IPO calendar in the coming week, including leading mortgage lender Rocket Companies...read more
No trial, no problem: Biggest week for preclinical biotech IPOs ever
Three large preclinical biotech IPOs are slated to begin trading on Friday, the most ever in a single week. Vaxcyte (PCVX) is developing next-generation pneumonia vaccines, a $7 billion market, and expects to begin clinical trials for its...read more
US IPO Week Ahead: One biotech to close out February
Preclinical biotech Passage Bio (PASG) is the only IPO set to price in the coming week. Passage Bio plans to raise $126 million by offering 7.4 million shares at a price range of $16 to $18. At the midpoint, Passage Bio would command a...read more
Burning Up: Hot Streak for Biotechs Continues in 2020
The active market for biotech IPOs looks like it's going to continue in 2020. The latest to go public, preclinical gene therapy biotech Beam Therapeutics (BEAM) upsized its share offering by 69%, priced at the high end of the range, and...read more